Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Clinical trial NCT07122401 · RECRUITING
Trial details
- NCT number
- NCT07122401
- Sponsor
- Shaanxi Micot Pharmaceutical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2026-11-26
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.